Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Outlook Therapeutics Inc (OTLK)  
$8.60 0.10 (1.18%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 123,000,000
Market Cap: 1.06(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $6.78 - $11.94
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 6.9
Insider 6 Months    : 6.9
Insider 3/6 Months : 13.9
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Outlook Therapeutics is a late clinical-stage biopharmaceutical company focused on developing and launching ophthalmic formulation of bevacizumab approved by the U.S. Food and Drug Administration for use in retinal indications. ONS-5010 (LYTENAVA (bevacizumab-vikg)), Co.'s sole product candidate in active clinical development, is an investigational ophthalmic formulation of bevacizumab, which it is developing to be administered as an intravitreal injection for the treatment of wet age-related macular degeneration (AMD) and other retinal diseases. Co.'s clinical program for ONS-5010 in wet AMD involves three clinical trials, which it refers to as NORSE ONE, NORSE TWO and NORSE THREE.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 778,652 778,652 778,652 1,071,920
Total Buy Value $48,485 $48,485 $48,485 $414,759
Total People Bought 3 3 3 7
Total Buy Transactions 3 3 3 13
Total Shares Sold 0 0 0 951,155
Total Sell Value $0 $0 $0 $1,090,296
Total People Sold 0 0 0 2
Total Sell Transactions 0 0 0 5
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 151
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Syntone Ventures Llc   –       –       •   2024-04-15 4 B $0.00 $0 D/D 714,286 1,705,438 0.01 -1%     
   Haddadin Yezan Munther   –       •      –    2024-03-28 4 B $11.82 $22,242 D/D 1,882 5,049 0.01 -29%     
   Gms Ventures & Investments Director   –       •       •   2024-03-18 4 A $0.00 $0 I/I 2,305,714 5,808,074     -
   Evanson Jeff CHIEF COMMERCIAL OFFICER   •       –      –    2024-03-07 4 B $0.42 $26,243 D/D 62,484 808,459 0.01     -
   Dagnon Terry Chief Operations Officer   •       –      –    2023-04-20 4 S $1.14 $590,200 D/D (520,000) 653,058     -
   Evanson Jeff Chief Commercial Officer   •       –      –    2023-01-20 4 S $1.11 $296,370 D/D (267,000) 745,975     -
   Evanson Jeff Chief Commercial Officer   •       –      –    2023-01-19 4 S $1.22 $125,971 D/D (103,255) 1,012,975     -
   Evanson Jeff Chief Commercial Officer   •       –      –    2023-01-18 4 S $1.25 $42,173 D/D (33,738) 1,116,230     -
   Evanson Jeff Chief Commercial Officer   •       –      –    2023-01-17 4 S $1.31 $35,582 D/D (27,162) 1,149,968     -
   Gms Ventures & Investments Director   –       •       •   2022-12-28 4 A $0.88 $12,499,999 I/I 14,230,418 70,047,204     -
   Sukhtian Faisal Ghiath Director   –       •      –    2022-10-07 4 B $1.29 $38,700 D/D 30,000 68,000 2.39     -
   Haddadin Yezan Munther Director   –       •      –    2022-10-07 4 B $1.27 $4,572 D/D 3,600 63,343 2.31     -
   Haddadin Yezan Munther Director   –       •      –    2022-10-06 4 B $1.29 $38,368 D/D 29,743 59,743 2.39     -
   Hilzinger Kurt J Director   –       •      –    2022-10-05 4 B $1.23 $19,264 D/D 15,662 473,117 2.39     -
   Hilzinger Kurt J Director   –       •      –    2022-10-04 4 B $1.29 $123,248 D/D 95,541 457,455 2.39     -
   Hilzinger Kurt J Director   –       •      –    2022-10-03 4 B $1.25 $52,248 D/D 41,798 361,914 2.39     -
   Hilzinger Kurt J Director   –       •      –    2022-09-30 4 B $1.26 $41,831 D/D 33,199 320,116 2.39     -
   Hilzinger Kurt J Director   –       •      –    2022-09-29 4 B $1.19 $16,422 D/D 13,800 286,917 2.39     -
   Dagnon Terry Chief Operating Officer   •       –      –    2022-06-21 4 B $1.05 $10,500 D/D 10,000 1,173,058 2.74     -
   Trenary C Russell III CEO and President   •       •      –    2022-06-21 4 B $1.06 $21,121 D/D 19,925 54,925 2.81     -
   Gms Tenshi Holdings Pte. Ltd 10% Owner   –       –       •   2022-04-21 4 D $0.00 $0 D/D (27,982,529) 22,982,529     -
   Gms Ventures & Investments Director   –       •       •   2022-04-21 4 A $0.00 $0 I/I 27,982,529 55,816,786     -
   Hilzinger Kurt J Director   –       •      –    2022-03-01 4 B $1.69 $46,827 D/D 27,708 273,117 2.39     -
   Hilzinger Kurt J Director   –       •      –    2022-02-28 4 B $1.60 $9,600 D/D 6,000 245,409 2.39     -
   Hilzinger Kurt J Director   –       •      –    2022-02-24 4 B $1.46 $60,094 D/D 41,160 239,409 2.39     -
  151 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us